Century Therapeutics (IPSC) Net Equity Issued and Repurchased (2021 - 2026)
Century Therapeutics' (IPSC) quarterly Net Equity Issued and Repurchased came in at $202000.0 in Q1 2026, up 68.33% year-on-year from $120000.0 in Q1 2025, and up 281.13% on a QoQ basis from $53000.0 in Q4 2025.
Century Therapeutics (IPSC) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $202000.0 in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased rose 68.33% year-over-year to $202000.0 in Q1 2026; TTM through Mar 2026 was $255000.0, a 342.86% increase from a year earlier, with the FY2025 full-year figure at $173000.0, up 22.7% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $202000.0, up from $53000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for IPSC reached as high as $448000.0 in Q1 2023 and fell as low as -$602000.0 in Q4 2024.
- Historically, Net Equity Issued and Repurchased has averaged $91800.0 across 5 years, with a median of $120000.0 in 2025.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 589.23% in 2023 and fell as far as 474.74% in 2023.
- Year by year, Net Equity Issued and Repurchased stood at $95000.0 in 2022, then slumped by 474.74% to -$356000.0 in 2023, then sank by 69.1% to -$602000.0 in 2024, then surged by 108.8% to $53000.0 in 2025, then jumped by 281.13% to $202000.0 in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $202000.0 in Q1 2026, $53000.0 in Q4 2025, and $120000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 141.90 Mn |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | 202,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | -602,000.00 |
| Dec 31, 2024 | -602,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Dec 31, 2023 | -356,000.00 |
| Dec 31, 2023 | -356,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 124,000.00 |
| Jun 30, 2023 | 124,000.00 |